Atherogenic index of plasma and its cardiovascular risk factor correlates among patients with type 2 diabetes in Uganda

Abstract

Background: Atherogenic Index of Plasma (AIP) is a reliable predictor of coronary artery disease. There is paucity of data on AIP and its correlates among patients with type 2 diabetes (T2D) in Uganda.
 Objective: To assess the profile of AIP and its cardiovascular risk factor correlates among patients with T2D in Uganda.
 Methods: This was a cross-sectional study conducted in 8 health facilities with established T2D clinics in Central-Uganda. The study enrolled 500 patients aged 40 to 79 years. Data was collected on socio-demographic characteristics, lipid profile and glycated haemoglobin (HbA1c). The AIP was derived using log (triglycerides/high-density cholesterol) and further categorised as low cardiovascular disease (CVD) risk if the AIP was <0.1, intermediate risk (0.1-0.24) and high risk (≥0.24). Cardiovascular risk factors were defined according to international guidelines. Stata version 14 was used to analyse data, Pearson correlation analyses were conducted. Statistical significance was set at p<0.05.
 Results: There were 389(77.4%) females with a mean age of 55.07±8. 979 years. Low-risk was found in 43.6%, intermediate risk in 20.2% and high risk in 36.2% of the participants. AIP significantly correlated with waist circumference (r=0.1095, p<0.0147), waist-hip ratio (r=0.1926, p<0.001), Casteri Risk Index I (r=0.506, r=<0.001), Casteri Risk Index II (r=0.246, p<0.001) and atherogenic coefficient (r=0.186, p<0.001). Insignificant correlation was observed between AIP and fasting blood sugar (r=0.017, p=0.7042), HBA1C (r=0.0108, p=0.8099) and diabetes duration (r=0.0445, p=0.32)
 Conclusions: AIP is significantly elevated and correlated with cardiovascular risk factors in patients with T2D. In clinical management, this may be a useful tool in risk stratifying patients with T2D.
 Keywords: Atherogenic index of plasma; Type 2 diabetes; cardiovascular risk factors; Uganda.

Prevalence of dyslipidemia among persons with type 2 diabetes in Africa: a systematic review and meta-analysis

“…Nigeria was the most prominently represented, with 14 articles 22 – 35 . This was followed by Ghana ( n =13) 36 – 48 , Ethiopia ( n =12) 49 – 60 , South Africa ( n =5) 61 – 65 , Kenya ( n =3) 66 – 68 , Sudan ( n =3) 69 – 71 , Eritrea ( n =2) 72 , 73 , and one article each from Algeria 74 , Egypt 75 , Morocco 76 , Somalia 77 , Tanzania 78 , Uganda 79 , and Zambia 80 . In total, 20 034 participants were studied, with sample sizes ranging from 100 to 2352.…”

Editor’s choice: COVID-19 and other infections in Africa

“…The non-communicable disease section includes papers on cancer 43 – 52 ; cardiovascular disease 53 – 55 ; and mental health 56 – 57 . The rest of the papers touch on several aspects of other non-communicable disease, surgery, training and health systems issues.…”